COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

News Releases

News Releases

Date
Title
Document
December 18, 2015
BioDelivery Sciences Provides Pipeline Update
PDF Version
December 16, 2015
BioDelivery Sciences Announces Organizational Changes
PDF Version
December 3, 2015
BioDelivery Sciences Hires Joseph M. Lockhart as Vice President of Manufacturing and Supply Chain
PDF Version
November 24, 2015
BioDelivery Sciences to Present at the 27th Annual Piper Jaffray Healthcare Conference
PDF Version
November 11, 2015
BioDelivery Sciences to Present at the Jefferies 2015 Global Healthcare Conference
PDF Version
November 9, 2015
BioDelivery Sciences Provides Corporate Update and Reports Third Quarter 2015 Financial Results
PDF Version
November 2, 2015
BioDelivery Sciences to Host Conference Call and Webcast of Third Quarter 2015 Results on Monday, November 9
PDF Version
October 26, 2015
FDA Approval of BELBUCA™ (CIII) (Buprenorphine HCl) Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals
PDF Version
October 15, 2015
BioDelivery Sciences Announces FDA Approval of Change in BUNAVAIL® Product Specification Allowing for Immediate Release of Product
PDF Version
October 14, 2015
BioDelivery Sciences Announces Short-Term Supply Constraints for BUNAVAIL®
PDF Version

Investor Presentation

More information is coming soon.


Upcoming Events

BDSI Third Quarter 2020 Financial Results Call and Webcast
 Nov 5, 2020 at 8:30 AM EST

Stay Connected

Stay up to date on the latest news

Get started now
October 14, 2020 /
Data provided by West LLC. Minimum 15 minutes delayed.